Home ETF List About

Portfolio Holdings Detail for ISIN IE00B5BMR087
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCSP1(GBX) LSE
ETF TickerSXR8(EUR) F
ETF TickerCSP1.LS(GBX) CXE
ETF TickerCSPX.AS(EUR) CXE
ETF TickerCSPX.LS(USD) CXE
ETF TickerCSSPX.MI(EUR) CXE
ETF TickerCSSPXz(USD) CXE
ETF TickerSXR8.DE(EUR) CXE
ETF TickerCSSPX(EUR) ETF Plus
ETF TickerCSPX(EUR) Euronext Amsterdam
ETF TickerCSP1.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Core S&P 500 UCITS ETF USD (Acc) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-09-29 (Monday)1,879,834USD 1,365,718,199USD 1,365,718,199
2025-09-26 (Friday)1,878,853USD 1,361,304,153USD 1,361,304,153
2025-09-25 (Thursday)1,877,652LLY holding increased by 1526USD 1,341,751,343LLY holding decreased by -50052730USD 1,341,751,3431,526USD -50,052,730 USD 714.59 USD 741.85
2025-09-24 (Wednesday)1,876,126LLY holding increased by 17761USD 1,391,804,073LLY holding decreased by -25998336USD 1,391,804,07317,761USD -25,998,336 USD 741.85 USD 762.93
2025-09-18 (Thursday)1,858,365LLY holding increased by 109USD 1,417,802,409LLY holding increased by 5286276USD 1,417,802,409109USD 5,286,276 USD 762.93 USD 760.13
2025-09-17 (Wednesday)1,858,256LLY holding increased by 981USD 1,412,516,133LLY holding decreased by -7760632USD 1,412,516,133981USD -7,760,632 USD 760.13 USD 764.71
2025-09-16 (Tuesday)1,857,275LLY holding increased by 436USD 1,420,276,765LLY holding increased by 31008394USD 1,420,276,765436USD 31,008,394 USD 764.71 USD 748.19
2025-09-15 (Monday)1,856,839USD 1,389,268,371USD 1,389,268,371
2025-09-12 (Friday)1,855,749USD 1,401,814,237USD 1,401,814,237
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00B5BMR087

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY1,526 714.590* 800.54
2025-09-24BUY17,761 741.850* 800.87
2025-09-18BUY109 762.930* 801.08
2025-09-17BUY981 760.130* 801.31
2025-09-16BUY436 764.710* 801.51
2025-09-11BUY545 756.280* 801.77
2025-09-09BUY545 750.610* 802.33
2025-09-08BUY218 738.640* 802.69
2025-09-05BUY2,507 727.210* 803.13
2025-09-02BUY2,289 735.190* 803.53
2025-08-22BUY109 711.680* 804.06
2025-08-21BUY327 709.820* 804.62
2025-08-20BUY436 705.440* 805.20
2025-08-19BUY654 703.210* 805.81
2025-08-01BUY1,962 762.330* 806.07
2025-07-31SELL-1,826 740.070* 806.47 Profit of 1,472,613 on sale
2025-07-30BUY872 760.080* 806.75
2025-07-29BUY109 762.950* 807.02
2025-07-24BUY109 805.430* 807.03
2025-07-23BUY654 798.890* 807.08
2025-07-22BUY981 776.440* 807.27
2025-07-21BUY218 762.180* 807.55
2025-07-18SELL-1,091 771.710* 807.77 Profit of 881,282 on sale
2025-07-17BUY109 761.500* 808.07
2025-07-16BUY436 789.800* 808.18
2025-07-15SELL-1,665 771.750* 808.42 Profit of 1,346,015 on sale
2025-07-11SELL-218 793.010* 808.52 Profit of 176,257 on sale
2025-07-10BUY872 790.650* 808.63
2025-07-09BUY872 786.920* 808.77
2025-07-08BUY656 777.660* 808.98
2025-07-07SELL-2,507 772.870* 809.22 Profit of 2,028,712 on sale
2025-07-02SELL-3,161 779.280* 809.81 Profit of 2,559,800 on sale
2025-06-30BUY1,853 779.530* 810.01
2025-06-27BUY981 775.450* 810.25
2025-06-25SELL-218 792.300* 810.48 Profit of 176,684 on sale
2025-06-24BUY113 778.080* 810.71
2025-06-23BUY2,834 770.640* 810.99
2025-06-20BUY5,380 762.730* 811.33
2025-06-18SELL-654 785.030* 811.71 Profit of 530,857 on sale
2025-06-13SELL-327 819.360* 811.83 Profit of 265,469 on sale
2025-06-12BUY327 812.030* 811.83
2025-06-11BUY436 808.610* 811.86
2025-06-06SELL-545 769.880* 812.50 Profit of 442,814 on sale
2025-06-05SELL-327 765.680* 812.86 Profit of 265,806 on sale
2025-06-04SELL-436 765.840* 813.23 Profit of 354,567 on sale
2025-06-02BUY1,417 747.120* 814.24
2025-05-30SELL-315 737.670* 814.85 Profit of 256,677 on sale
2025-05-29BUY109 722.570* 815.59
2025-05-28SELL-109 719.390* 816.36 Profit of 88,983 on sale
2025-05-27BUY1,199 725.220* 817.10
2025-05-23SELL-2,180 713.710* 818.81 Profit of 1,785,010 on sale
2025-05-22SELL-2,398 715.200* 819.68 Profit of 1,965,581 on sale
2025-05-21BUY109 724.950* 820.47
2025-05-20BUY872 747.010* 821.09
2025-05-19BUY3,161 755.110* 821.66
2025-05-16BUY2,943 757.390* 822.21
2025-05-15BUY2,398 733.290* 822.98
2025-05-14BUY2,180 715.560* 823.93
2025-05-13SELL-436 746.060* 824.62 Profit of 359,533 on sale
2025-05-12BUY109 755.570* 825.23
2025-05-09BUY327 734.570* 826.05
2025-05-08SELL-3,161 751.450* 826.73 Profit of 2,613,287 on sale
2025-05-07SELL-1,526 776.720* 827.19 Profit of 1,262,287 on sale
2025-05-06BUY3,815 775.120* 827.67
2025-05-02BUY327 823.620* 827.77
2025-05-01SELL-545 794.100* 828.09 Profit of 451,307 on sale
2025-04-30BUY327 898.950* 827.40
2025-04-29BUY763 885.200* 826.84
2025-04-28BUY1,627 877.290* 826.35
2025-04-25BUY1,526 884.540* 825.77
2025-04-24BUY436 859.730* 825.43
2025-04-23BUY1,199 829.420* 825.39
2025-04-22SELL-662 827.540* 825.37 Profit of 546,396 on sale
2025-04-17BUY218 839.960* 825.14
2025-04-16BUY3,213 734.900* 826.10
2025-04-15BUY2,180 757.180* 826.84
2025-04-11BUY2,725 732.410* 828.68
2025-04-10BUY4,469 720.910* 829.87
2025-04-09BUY872 753.710* 830.73
2025-04-08BUY2,289 726.240* 831.92
2025-04-07BUY2,612 723.730* 833.16
2025-04-04SELL-6,540 738.210* 834.26 Profit of 5,456,093 on sale
2025-04-02BUY763 818.220* 834.45
2025-03-31SELL-2,943 825.910* 834.91 Profit of 2,457,137 on sale
2025-03-28SELL-1,853 822.510* 835.06 Profit of 1,547,366 on sale
2025-03-27SELL-545 821.670* 835.23 Profit of 455,198 on sale
2025-03-26BUY981 826.760* 835.33
2025-03-25SELL-1,308 852.350* 835.12 Profit of 1,092,331 on sale
2025-03-24BUY763 864.900* 834.73
2025-03-21BUY4,257 837.570* 834.70
2025-03-19BUY204 837.010* 834.56
2025-03-18SELL-1,944 822.510* 834.72 Profit of 1,622,704 on sale
2025-03-17BUY2,052 824.760* 834.86
2025-03-14BUY1,836 813.480* 835.16
2025-03-13BUY9,060 801.650* 835.63
2025-03-12BUY4,320 821.860* 835.83
2025-03-11BUY1,728 824.060* 836.00
2025-03-07BUY1,032 869.580* 835.59
2025-03-06SELL-972 912.760* 834.42 Profit of 811,056 on sale
2025-03-05BUY3,360 929.720* 832.95
2025-03-04BUY648 911.060* 831.73
2025-03-03BUY2,916 929.720* 830.18
2025-02-28SELL-756 920.630* 828.72 Profit of 626,511 on sale
2025-02-27BUY108 905.160* 827.47
2025-02-26SELL-216 915.010* 826.01 Profit of 178,417 on sale
2025-02-25BUY2,052 901.800* 824.72
2025-02-21BUY1,512 873.680* 822.87
2025-02-20BUY864 873.120* 821.97
2025-02-19BUY216 867.050* 821.15
2025-02-18BUY540 857.200* 820.48
2025-02-13BUY1,836 871.860* 818.54
2025-02-12BUY648 872.970* 817.46
2025-02-11SELL-216 865.000* 816.48 Profit of 176,361 on sale
2025-02-07SELL-864 878.310* 814.05 Profit of 703,343 on sale
2025-02-06BUY432 870.370* 812.83
2025-02-04BUY3,780 826.070* 811.86
2025-02-03BUY1,404 810.430* 811.90
2025-01-31BUY324 811.080* 811.91
2025-01-30BUY216 823.230* 811.64
2025-01-29BUY2,052 804.080* 811.83
2025-01-28BUY972 804.990* 812.00
2025-01-27BUY1,512 808.170* 812.10
2025-01-24BUY972 785.410* 812.83
2025-01-23BUY2,808 766.600* 814.11
2025-01-22BUY1,836 753.980* 815.83
2025-01-06BUY1,080 765.100* 817.32
2024-12-10BUY763 799.580* 817.86
2024-12-09BUY872 803.580* 818.30
2024-12-06BUY1,308 826.710* 818.03
2024-12-05BUY327 825.620* 817.78
2024-12-04BUY1,199 829.840* 817.36
2024-12-03BUY3,842 813.330* 817.51
2024-12-02BUY322 799.800* 818.16
2024-11-29BUY1,488 795.350* 819.04
2024-11-27BUY2,943 788.190* 821.61
2024-11-26BUY6,322 789.320* 823.02
2024-11-25BUY6,540 755.000* 826.11
2024-11-22BUY7,630 748.010* 829.83
2024-11-21BUY1,199 749.920* 833.82
2024-11-20BUY1,090 753.410* 838.05
2024-11-19BUY981 729.730* 844.07
2024-11-18BUY8,829 727.200* 850.95
2024-11-12BUY3,052 818.860* 852.95
2024-11-11BUY2,071 832.440* 854.32
2024-11-08BUY1,562 831.540* 855.95
2024-11-07BUY9,701 797.450* 860.45
2024-11-06BUY2,943 776.380* 867.45
2024-11-05BUY4,342 806.060* 873.03
2024-11-04BUY763 806.140* 879.72
2024-11-01BUY1,744 818.930* 886.48
2024-10-31BUY432 829.740* 893.57
2024-10-30BUY1,074 846.830* 900.25
2024-10-29BUY2,592 903.580* 899.69
2024-10-28SELL-756 895.590* 900.51 Profit of 680,786 on sale
2024-10-25BUY1,296 892.700* 902.46
2024-10-24BUY864 891.320* 906.18
2024-10-23BUY1,080 903.250* 907.64
2024-10-22BUY2,791 909.150* 906.13
2024-10-21BUY3,024 906.130* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.